Watchlist Price Alert

Boston Scientific Corpora... (BSX)

NYSE: BSX · Real-Time Price · USD

105.29

0.71 (0.68%)

At close: Jun 27, 2025, 9:33 AM

Boston Scientific Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	1.85B	1.59B	698M	1.04B	-82M	4.7B	1.67B	104M	347M
Depreciation & Amortization	1.27B	1.2B	1.14B	1.09B	1.12B	1.01B	894M	844M	815M
Stock-Based Compensation	266M	233M	220M	194M	170M	157M	140M	127M	116M
Other Working Capital	n/a	10M	-209M	-134M	-316M	27M	-1.26B	8M	-381M
Other Non-Cash Items	54M	253M	540M	17M	337M	551M	-148M	40M	3M
Deferred Income Tax	n/a	-1M	-63M	-124M	-82M	-4.3B	-87M	245M	-305M
Change in Working Capital	n/a	-770M	-1B	-351M	42M	-282M	-2.16B	66M	-4M
Operating Cash Flow	3.44B	2.5B	1.53B	1.87B	1.51B	1.84B	310M	1.43B	972M
Capital Expenditures	-790M	-800M	-612M	-554M	-376M	-461M	-316M	-319M	-376M
Cash Acquisitions	-4.64B	-1.81B	-1.54B	-1.43B	12M	-4.29B	-1.45B	-560M	-408M
Purchase of Investments	n/a	n/a	-24M	96M	-146M	-348M	-172M	-131M	-132M
Sales Maturities Of Investments	n/a	n/a	56M	294M	12M	59M	14M	131M	n/a
Other Investing Acitivies	-257M	-52M	106M	-1M	87M	1M	1M	-131M	29M
Investing Cash Flow	-5.69B	-2.57B	-2.01B	-1.6B	-411M	-5.04B	-1.92B	-1.01B	-887M
Debt Repayment	1.83B	-4M	-165M	n/a	-999M	2.79B	1.41B	123M	-190M
Common Stock Repurchased	n/a	182M	136M	110M	-535M	n/a	n/a	n/a	n/a
Dividend Paid	n/a	-28M	-55M	-55M	-28M	n/a	n/a	n/a	n/a
Other Financial Acitivies	-13M	37M	-464M	-40M	-95M	179M	27M	-98M	-127M
Financial Cash Flow	1.81B	5M	-548M	-95M	293M	2.97B	1.43B	110M	-206M
Net Cash Flow	-449M	-71M	-1.04B	173M	1.39B	-222M	-188M	530M	-123M
Free Cash Flow	2.65B	1.7B	914M	1.32B	1.13B	1.38B	-6M	1.11B	596M